BSEM

BioStem Technologies, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$1.3

Price (1 Year)

$7.15 $1.12

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.8 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %6 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use.

Website

Analysis (Turkish): BSEM Hissesi Caiz mi, Helal mi? BioStem Technologies, Inc. Katılım Analizi